Plain-English translation of NCT05937334 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that will follow 400 adults with asthma over at least two years. Researchers will collect information about your lung function, imaging scans, blood samples, and medical history to better understand asthma and identify which patients respond best to different treatments. No new experimental medications will be given — the study simply watches how asthma develops in people like you.
Asthma affects many people differently, and doctors don't always understand why some people respond well to treatment while others struggle. By following patients over time and analyzing blood markers, this study aims to discover the underlying reasons for these differences and help identify personalized treatment approaches in the future.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for baseline testing, which includes lung function tests, chest imaging scans, and blood draws. After that, you will be followed for at least two years with regular check-ups where researchers will collect information about your asthma, answer questionnaires about your health, and may repeat some tests. You will not be given any new experimental drugs — the study simply monitors your existing asthma care and collects data to help researchers learn more about the condition.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China
Sponsor
Beijing Chao Yang Hospital
Enrollment target
~400 participants
Started
January 2023
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Meishan Liu, M.D.
Beijing Chao Yang Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.